Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of the small bowel lesions detected by capsule endoscopy in patients with chronic kidney disease.
Kawamura H, Sakai E, Endo H, Taniguchi L, Hata Y, Ezuka A, Nagase H, Kessoku T, Yamada E, Ohkubo H, Higrashi T, Sekino Y, Koide T, Iida H, Nonaka T, Takahashi H, Inamori M, Maeda S, Nakajima A. Kawamura H, et al. Among authors: inamori m. Gastroenterol Res Pract. 2013;2013:814214. doi: 10.1155/2013/814214. Epub 2013 Aug 26. Gastroenterol Res Pract. 2013. PMID: 24065987 Free PMC article.
Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?
Inamori M, Togawa J, Takahashi K, Yoneda M, Fujisawa N, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H. Inamori M, et al. J Gastroenterol Hepatol. 2003 Sep;18(9):1034-8. doi: 10.1046/j.1440-1746.2003.03126.x. J Gastroenterol Hepatol. 2003. PMID: 12911659 Clinical Trial.
Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
Inamori M, Togawa J, Chiguchi G, Abe Y, Kikuchi T, Muramatsu K, Kawamura H, Kobayashi N, Kirikoshi H, Shimamura T, Sakaguchi T, Takamura T, Ueno N, Nakajima A. Inamori M, et al. J Gastroenterol. 2005 Feb;40(2):213-4. doi: 10.1007/s00535-004-1521-8. J Gastroenterol. 2005. PMID: 15770408 No abstract available.
Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J, Inamori M, Fujisawa N, Takahashi H, Yoneda M, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H. Togawa J, et al. Among authors: inamori m. Hepatogastroenterology. 2005 Mar-Apr;52(62):645-8. Hepatogastroenterology. 2005. PMID: 15816496 Clinical Trial.
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Shimamura T, Kubota K, Sakaguchi T, Saito S, Ueno N, Nakajima A. Inamori M, et al. J Gastroenterol. 2005 May;40(5):453-8. doi: 10.1007/s00535-005-1569-0. J Gastroenterol. 2005. PMID: 15942709 Clinical Trial.
327 results